Samil Pharm (000520) — Cash Flow Reinvestment Rate
Samil Pharm (000520) has a Cash Flow Reinvestment Rate of 2.71x as of June 2025, reinvesting ₩6.62 Billion (capex ₩3.26 Billion plus investments ₩-3.36 Billion) from operating cash flow of ₩2.44 Billion. Check Samil Pharm (000520) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Samil Pharm Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Samil Pharm across 10 annual periods. Explore Samil Pharm strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Samil Pharm (2012–2024)
Year-by-year capital reinvestment analysis for Samil Pharm. For live market cap and broader valuation context, see 000520 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.62x | ₩11.97 Billion | ₩2.59 Billion | ₩5.61 Billion | ▲ +22.9% |
| 2023 | 3.76x | ₩44.17 Billion | ₩11.75 Billion | ₩24.39 Billion | ▼ -73.9% |
| 2022 | 14.38x | ₩59.74 Billion | ₩4.15 Billion | ₩48.48 Billion | ▼ -52.2% |
| 2021 | 30.09x | ₩42.63 Billion | ₩1.42 Billion | ₩32.83 Billion | ▲ +711.2% |
| 2020 | 3.71x | ₩28.83 Billion | ₩7.77 Billion | ₩17.02 Billion | ▲ +117.0% |
| 2019 | 1.71x | ₩18.10 Billion | ₩10.59 Billion | ₩13.89 Billion | ▼ -84.7% |
| 2017 | 11.19x | ₩42.41 Billion | ₩3.79 Billion | ₩36.33 Billion | ▲ +762.2% |
| 2016 | 1.30x | ₩7.31 Billion | ₩5.63 Billion | ₩4.45 Billion | ▼ -69.9% |
| 2015 | 4.31x | ₩12.60 Billion | ₩2.92 Billion | ₩2.36 Billion | ▲ +1035.7% |
| 2012 | 0.38x | ₩1.91 Billion | ₩5.02 Billion | ₩1.91 Billion | — |